Close Menu

Breaking News

Different biological processes appear to drive body mass index during infancy and later in childhood and adulthood, which could inform obesity prevention strategies.

A genomic analysis of ancient and modern samples revealed population clusters and ancestral contributions stemming from historical migrations and admixture events.

The combined firm will be based in Gaithersburg, Maryland and will focus on infectious disease diagnostics and antimicrobial resistance prediction services. 

The group notes the importance of lab CLIA certification, clear test reports, and clinical validity support for test claims in the literature, guidelines, and FDA labels.

The center, launched by the National University of Ireland Galway, plans to train 115 doctoral students in genomics data science over the next seven years.

The company announced its European subsidiary priced an offering of €6.20 billion ($6.83 billion) in senior notes to fund part of its purchase of GE's Biopharma business.

The technology uses a proprietary chemistry that attaches primers to probes with a polyethylene glycol-based linker to prevent the formation of primer-dimers.

The company reported $10.7 million in total revenues for the quarter and said test report volume for its DecisionDx-Melanoma test grew 27 percent.

A European study, published today in NEJM, used a POC, PCR-based system to perform CYP2C19 genotyping to guide platelet inhibitor therapy.

The index, which slightly underperformed the Dow Jones, had a smaller loss in August than in the previous month.

Researchers uncovered six clusters among the more than 2,500 individuals they analyzed and noted varying degrees of Norse Viking ancestry in their cohort.

Based on runs of homozygosity, researchers estimated that roughly one in every 3,650 participants had parents who were first- or second-degree relatives.

The company, founded earlier this year, is developing a technology for the detection of low-frequency genetic mutations for diagnostic applications.

The genetic testing firm has entered into an equity distribution agreement with Piper Jaffray to offer up to $30 million in stocks, with an initial offering of $22.5 million.

Last week, GenomeWeb's readers were most interested in 10x Genomics executives telling existing customers not to worry about access to its assay kits.

The team found that base editors that exhibit RNA off-target editing can also self-edit their own transcripts, leading to heterogeneity in their coding sequences.

The partners plan to develop a number of liquid chromatography mass spectrometry methods for clinical research applications.

The single-cell sequencing firm originally said it was looking to raise $100 million in its initial public offering.

The company is developing a test to predict the  risk of a melanoma patient's cancer metastasizing in lymph nodes without the need for biopsy.

A population of progenitor cells identified in mouse models of the Sonic Hedgehog medulloblastoma subtype led to a gene that is highly expressed in patients with poor outcomes.

Researchers found that 14 percent of individuals with metastatic breast cancer had risky mutations germline mutations, including patients who did not meet testing criteria.

The US Court of Appeals for the Federal Circuit affirmed a lower-court decision in favor of Illumina, which Scripps had sued over marketing of bead-based microarrays.

Invitae reported that its recent acquisition Singular Bio had a net loss of $1.8 million in 2018 compared to a net loss of $3.3 million in 2017

The company hopes to develop AI-based tools to improve the usefulness of its ESCAPE platform, which combines single-cell sequencing with protein analysis.

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.